IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor

News
2020
2019
Archive

July 10, 2020

IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor
July 7, 2020

Cabaletta Bio and Artisan Bio Announce Gene Editing Research and Collaboration Agreement to Develop Next-Generation CAAR T Cell Therapies
July 7, 2020

Pear Therapeutics Announces $50 Million Credit Facility From Perceptive Advisors
July 7, 2020

Vor Biopharma Closes $110 Million Series B Financing
July 1, 2020

scPharmaceuticals Announces FUROSCIX® NDA Resubmission
June 30, 2020

Impel Neuropharma Announces Publication of Positive Results of SNAP 101 Study for INP105 for the Treatment of Acute Agitation in the Journal of Clinical Psyciatry
June 29, 2020

Cidara Therapeutics Added to Russell 3000® Index
June 29, 2020

Aprea Therapeutics Appoints Fouad Namouni, M.D. and Richard Peters, M.D., Ph.D. to Board of Directors
June 29, 2020

Artiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies
June 26, 2020

Akouos Announces Pricing of Initial Public Offering

1
2
3
…
7
Next Page »